ACE2 and COVID-19: In addition, binding of SARS-CoV-2 to ACE2 in enterocytes possibly results in reduced activation of canonical autophagy regulator mTOR, thereby enhancing intestinal autophagy and promoting the development of extrapulmonary COVID-19 clinical manifestations such as diarrhoea [55].